APPLICATIONS PUBLISHED 20 NOVEMBER 2002
            
    
                Published: 1-Jun-2003
    
    
            
            
                           
        
    
    The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
                         
                    
                    The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Electronic alarm timer for use with a medical regimen
Akzo Nobel	1257244*
Protection of the female reproductive system from natural and artificial insults
Sloan-Kettering Institute for Cancer Research	1257245*
Pharmaceutical compsn
Bentley Pharmaceuticals	1257248*
Formulations containing an anti-cholinergic drug for the treatment of chronic obstructive pulmonary disease
Cheisi Farmaceutici	1257254*
Therapeutic product, use and formulation thereof
Advanced Pharma	1257255*
Drug carrier pellet production process
Alpharma	1257256*
Delivery systems using preformed biodegradable polymer compsns and methods
3M Innovative Properties	1257257*
Bioadhesive compsn
National Starch and Chemical Treatment Investment Holding Corp	1257258*
Controlled release ceramic particles, compsns thereof, processes of preparation and methods of use
Australian Nuclear Science and Technology Organisation	1257259*
Powder formulation for inhalation
Rijksuniversiteit te Groningen	1257260*
Antiviral pharmaceutical compsns containing iron chelators
Faculteit Geneeskunde Universiteit Utrecht	1257261*
Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof
Novactyl	1254262*
Microcompetition and human disease
SCI Pharmaceuticals	1254263*
Estrogen receptor modulators
Merck & Co	1257264*
Use of 2-phenylene diamine derivatives for the treatment of infections
Jomaa Pharmaka	1257265*
Intravenous carnitine for the treatment of chronic uraemic patients undergoing periodic dialysis
Sigma-Tau Industrie Farmaceutiche Riunite	1257266*
Compsn for the prevention and/or treatment of lipid metabolism disorders and allergic forms
Sigma-Tau Healthscience	1257267*
Diagnostic and therapeutic compsns and methods for affecting tumour growth using oxygen mimetic agents
Novolytics	1257268*
Orally administratable acid stable anti-ulcer benzimidazole derivatives
Kopran Research Laboratories	1257269*
A method for stabilising leflunomide
Teva Pharmaceutical Industries	1257270*
Use of pramipexazole for the treatment of addictive disorders
Pharmacia & Upjohn	1257271*
Thiazolium compounds and treatments of disorders associated with protein aging
Alteon	1257272*
Improved treatment for acute physical insult to the central nervous system
University of Saskatchewan Technologies	1257273*
Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid for treating infectious diseases
Susilo, Rudy	1257274*
Use of central cannabinoid receptors antagonist for preparing medicines designed to facilitate smoking cessation
Sanofi-Synthelabo	1257275*
Antiviral azaindole derivatives
Bristol-Myers Squibb	1257276*
New drug combinations comprising a norepinephrine reuptake inhibitor and a antimuscarinic agent
Pharmacia & Upjohn	1257277*
The use of mirtazepine for the treatment of sleep disorders
Akzo Nobel	1257278*
Improvement of implantation rate using FF-MAS
Schering	1257279*
Drospirenone for hormone replacement therapy
Schering	1257280*
Nucleoside analogues with carboxamidine modified monocyclic base
ICN Pharmaceuticals	1257281*
Pancreatic stem cells and their use in transplantation
The General Hospital Corp	1257282*
Compsns suitable for oral administration and kits and methods thereof for hydrating mammalian skin
Procter & Gamble	1257283*
A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
The Regents of the University of California	1257284*
Use of breast cancer associated membrane proteins (BCMO) for treatment, prophylaxis and diagnosis of breast cancer
Oxford Glycosciences (UK)	1257285*
Cancer treatment and prodrugs involving HES-1 protein
Karo Bio	1257286*
Compsns and methods for the early diagnosis of ovarian cancer
The Board of Trustees of the University of Arkansas	1257287*
Methods for regulating IL-10 with IL-9, and applications thereof
Ludwig Institute for Cancer Research	1257288*
Immunotherapy using interleukin 13 receptor subunit alpha 2
The Penn State University Foundation	1257289*
Method for antigen-specific stimulation of T-lymphocytes with synthetic peptide libraries
Kern, Florian	1257290*
Novel antibody with specificity for colon cancer
Active Biotech	1257291*
Use of IL-18 inhibitors
Applied Research Systems Holding; Yeda Research and Development Company	1257292*
Immunomodulatory effective compounds, methods for the production thereof and their use
Kleine & Stube Endotoxin	1257293*
Carrier particles for drug delivery and process for their preparation
Ottowa Heart Institute Research Corporation	1257294*
Factor VII or VIIA-type molecules
Maxygen Aps; Maxygen Holdings	1257295*
Caspase activated prodrugs therapy
Genentech	1257296*
Compsns and methods for treatment of angiogenesis in pathological lesions
Philogen	1257297*
Cosmid DNA constructs and methods of making and using the same
The Trustees of the University of Pennsylvania	1257298*
Radioactive therapeutic liposomes
Anticancer Therapeutic Inventions	1257299*
A process for the preparation of salts of L-carnitine and alkanoyl L-carnitine with mucic acid
Sigma-Tau Industrie Farmaceutiche Riunite	1257524*
Stabilising agent for hydroxylamine solutions
BASF	1257525*
Aniline-derived ligands for the thyroid receptor
Bristol-Myers Squibb	1257526*
(2S)-aminoindan derivatives, a process for their preparation, and their use as selective dopamine D3 ligands
Pharmacia & Upjohn	1257527*
Aminoalcohol derivatives
Fujisawa Pharmaceuticals	1257528*
Method for producing nitroguanidine
Dynamit Nobel GmbH Explosivstoff- und Systemtechnik	1257529*
Aminosulfonylbiphenyl derivatives
Merck Patent	1257530*
Method for the preparation of carbothioic acids
Abbott Laboratories	1257531*
Process for the preparation of (e)-caprolactam
DSM	1257532*
New coupling process
AstraZeneca	1257533*
Novel process for preparing 4-substituted-1H-pyrrole-3-carboxylic acid ester
LG Chem Investment	1257534*
Substituted pyridine compounds useful for controlling chemical synaptic transmission
Abbott Laboratories	1257535*
Substituted nicotinamides and analogues as activators of caspases and inducers of apoptosis and the use thereof
Cytovia	1257536*
Therapeutic morpholino-substituted compounds
Kinacia	1257537*
9-alkylamino-1-nitroacridine derivatives
New York Medical College	1257538*
Amino pyrazole derivatives useful for the treatment of obesity and other disorders
Ortho-McNeill Pharmaceuticals	1257539*
Method for the production of 1-amino-3-aryl-uracils
Bayer	1257540*
Method for producing 2-(1,2,4-traizol-1-yl)-ethanols
Bayer	1257542*
Pyridinylimidazoles
SmithKline Beecham	1257543*
Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
Vertex Pharmaceuticals	1257544*
Selective IGLUR 5 receptor antagonists
Eli Lilly	1257545*
Kinase inhibitors
Amgen	1257546*
1,3-disubstituted pyrrolidines as alpha-2-adrenoreceptor antagonists
Novartis	1257547*
Benzofuran carboxamides and their therapeutic use
Darwin Discovery	1257548*
Matrix metalloproteinase inhibitors and uses thereof
Bristol-Myers Squibb Pharma	1257549*
Platelet ADP receptor inhibitors
COR Therapeutics	1257550*
Heterocyclic compounds and their use as PARP inhibitors
BASF	1257551*
Xanthine derivatives, intermediates and use for treating osteoporosis
Aventis Pharma	1257552*
Pyrrolopyrimidinone derivatives, process of preparation and use
SK Chemicals; In2gen 	1257553*
Benzoxathiepino(3,4-B)bipyridine derivatives, process for their preparation and their use as medicaments
Ortho-McNeill Pharmaceutical	1257554*
Pyrimidine compounds and their use as modulators of chemokine receptor activity
AstraZeneca	1257555*
Thiazolopyrimidines and their use as modulators of chemokine receptor activity
AstraZeneca	1257556*
Method for producing N-(phosphonomethyl)glycine
Degussa	1257557*
Methods for synthesis of alpha-D-gal (1,3) gal-containing oligosaccharides
Alchemica	1257558*
Mammalian sphingosine-1-phosphate phosphatase
Merck	1257559*
BCL-2-like polynucleotides, polypeptides, and antibodies
Human Genome Sciences	1257560*
Staphylococcyl GTPase OBGcleotide sequence encoding staphylococcyl GTP-binding protein
Anadys Pharmaceuticals	1257561*